Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
29 Dezember 2023 - 2:02PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-163
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of December 2023
Alterity
Therapeutics Limited
(Name
of Registrant)
Level 14, 350 Collins Street,
Melbourne, Victoria 3000 Australia
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980
and 333-228671) and our
Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417
and 333-250076)
ALTERITY
THERAPEUTICS LIMITED
(a
development stage enterprise)
The
following exhibits are submitted:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Alterity Therapeutics Limited |
|
|
|
By: |
/s/ Geoffrey P. Kempler |
|
|
Geoffrey P. Kempler |
|
|
Chairman |
Date:
December 29, 2023
2
Exhibit 99.1
Results of Extraordinary General
Meeting
MELBOURNE, AUSTRALIA AND SAN
FRANCISCO, USA - 29 December 2023 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”)
advises that all resolutions considered at the Extraordinary General Meeting held today were carried by poll.
In accordance with ASX Listing rule 3.13.2
and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.
Phillip Hains
Company Secretary
Alterity Therapeutics Limited
ACN 080 699 065
Level 3, 62 Lygon Street Carlton
Victoria 3053 Australia
www.alteritytherapeutics.com
Alterity Therapeutics Limited
Extraordinary General Meeting
Friday, 29 December 2023
Results of Meeting |
|
|
The following information is provided in accordance with
section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.
Resolution details |
Instructions given to validly appointed proxies (as at proxy close) |
Number of votes cast on the poll (where applicable) |
Resolution Result |
Resolution |
Resolution Type |
For |
Against |
Proxy's Discretion |
Abstain |
For |
Against |
Abstain* |
Carried / Not Carried |
1 Ratification of prior issue of Shares |
Ordinary |
150,828,432 81.93% |
29,952,074 16.27% |
3,312,470 1.80% |
2,351,400 |
154,140,902 83.73% |
29,952,074 16.27% |
6,351,400 |
Carried |
2 Approval for issue of Shares |
Ordinary |
139,071,294 76.58% |
39,235,586 21.60% |
3,312,470 1.82% |
4,845,426 |
142,383,764 78.40% |
39,235,586 21.60% |
8,845,426 |
Carried |
3 Approval for issue of Options |
Ordinary |
138,253,594 76.54% |
39,033,686 21.61% |
3,332,470 1.85% |
5,644,626 |
141,586,064 78.39% |
39,033,686 21.61% |
9,644,626 |
Carried |
4 Approval for issue of Securities - SPP |
Ordinary |
135,532,712 73.88% |
44,583,474 24.30% |
3,332,470 1.82% |
4,850,126 |
130,648,470 74.56% |
44,583,474 25.44% |
17,066,838 |
Carried |
5A Approval of issue of Securities - Placement - Peter Marks |
Ordinary |
136,391,908 73.89% |
45,181,628 24.47% |
3,024,662 1.64% |
3,543,984 |
139,416,570 75.52% |
45,181,628 24.48% |
7,543,984 |
Carried |
5B Approval of issue of Securities - Placement - Brian Meltzer |
Ordinary |
135,291,600 73.16% |
45,622,628 24.67% |
4,016,970 2.17% |
3,327,984 |
139,308,570 75.33% |
45,622,628 24.67% |
7,327,984 |
Carried |
5C Approval of issue of Securities - Placement - Lawrence Gozlan |
Ordinary |
136,345,000 73.71% |
45,610,628 24.66% |
3,016,970 1.63% |
3,326,184 |
139,361,970 75.34% |
45,610,628 24.66% |
7,326,184 |
Carried |
* Votes cast by a person who abstains on an item are not
counted in calculating the required majority on a poll.
Alterity Therapeutics (NASDAQ:ATHE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Alterity Therapeutics (NASDAQ:ATHE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024